Alpix Shares Early Beta Insights on AI-Assisted Trading and On-Chain Perpetuals Platform 
Heavyweight Endorsement from Top-tier Cornerstone Investors! Sigenergy (06656.HK) Launches IPO: Led by Temasek and Goldman Sachs, the AI Energy Storage Leader Ignites Hong Kong’s New Stock Frenzy 
Shoucheng Holdings (0697.HK) Combines Dividends and Share Buybacks in Tandem, Returning Approximately HK$6.877 Billion to Shareholders Over Eight Years 
Formerra Announces Global Price Increase 
U.S. Polo Assn. and ESPN Champion the Iconic USPA Gold Cup at the USPA National Polo Center, Hosted by Legendary Commentator Chris Fowler Denali Therapeutics Announces Initiation of Phase 1b Study of EIF2B Activator DNL343 in ALS
— Investigational EIF2B activator approach has potential to be a first-in-class treatment for ALS — SOUTH…
Syneos Health and Ride Health Partner to Improve Clinical Trial Recruitment and Retention
Partnership Creates a More Patient-centric Travel Experience, Drives Adherence and Advances Diversity and Inclusion in…
TG Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
Fireside chat available for on demand download at 7:00 AM ET on Monday, September 13,…
Medicenna Therapeutics to Present at Upcoming September Investor Conferences
TORONTO and HOUSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…
PharmaTher to Present at H.C. Wainwright 23rd Annual Global Investment Conference
To provide an update on PharmaTher’s product pipeline and upcoming milestones on its FDA Phase…
Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its Novel Psilocybin-Inspired Clinical Candidate
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Alpha Cognition to Webcast Live at Life Sciences Investor Forum September 16th
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time,…
Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
DURHAM, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage…
AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned…
Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
WOBURN, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural…
Fortress Biotech to Participate in Three September 2021 Investor Conferences
NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an…
Checkpoint Therapeutics to Participate in Two Upcoming Investor Conferences
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a…
Mustang Bio to Participate in Three September 2021 Investor Conferences
WORCESTER, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Paratek Pharmaceuticals to Present at H.C. Wainwright 23rd Annual Global Investment Conference
BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease
Only clinical-stage candidate for Huntington’s disease designed to selectively lower mutant HTT and spare wild-type…
Palisade Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
CARLSBAD, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) a late-stage…
PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
FLORHAM PARK, N.J., Sept. 09, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Veru Announces Oral Presentation of Updated Data from the Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
MIAMI, Sept. 09, 2021 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company…
BioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in the U.S. and Canada
Expands Portfolio and Establishes Growth Platform in Neurology The First and Only FDA-Approved, Ready-to-Use Oral…
Levitee Labs Commences Trading in U.S. Under Ticker LVTTF
The Company has Listed its Securities for Trading on the OTC Markets VANCOUVER, British Columbia,…